366 related articles for article (PubMed ID: 8113996)
1. Characterization of [3H]naltrindole binding to delta opioid receptors in mouse brain and mouse vas deferens: evidence for delta opioid receptor heterogeneity.
Fang L; Knapp RJ; Horvath R; Matsunaga TO; Haaseth RC; Hruby VJ; Porreca F; Yamamura HI
J Pharmacol Exp Ther; 1994 Feb; 268(2):836-46. PubMed ID: 8113996
[TBL] [Abstract][Full Text] [Related]
2. Postnatal development of delta-opioid receptor subtypes in mice.
Negri L; Severini C; Lattanzi R; Potenza RL; Melchiorri P
Br J Pharmacol; 1997 Mar; 120(6):989-94. PubMed ID: 9134207
[TBL] [Abstract][Full Text] [Related]
3. Evidence for a single functional opioid delta receptor subtype in the mouse isolated vas deferens.
Wild KD; Carlisi VJ; Mosberg HI; Bowen WD; Portoghese PS; Sultana M; Takemori AE; Hruby VJ; Porreca F
J Pharmacol Exp Ther; 1993 Feb; 264(2):831-8. PubMed ID: 8382281
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, opioid receptor binding, and bioassay of naltrindole analogues substituted in the indolic benzene moiety.
Ananthan S; Johnson CA; Carter RL; Clayton SD; Rice KC; Xu H; Davis P; Porreca F; Rothman RB
J Med Chem; 1998 Jul; 41(15):2872-81. PubMed ID: 9667975
[TBL] [Abstract][Full Text] [Related]
5. [3H]naltrindole: a potent and selective ligand for labeling delta-opioid receptors.
Contreras PC; Tam L; Drower E; Rafferty MF
Brain Res; 1993 Feb; 604(1-2):160-4. PubMed ID: 8384509
[TBL] [Abstract][Full Text] [Related]
6. Design of peptidomimetic delta opioid receptor antagonists using the message-address concept.
Portoghese PS; Sultana M; Takemori AE
J Med Chem; 1990 Jun; 33(6):1714-20. PubMed ID: 2160538
[TBL] [Abstract][Full Text] [Related]
7. The selectivity of the opioid antagonist, naltrindole, for delta-opioid receptors.
Rogers H; Hayes AG; Birch PJ; Traynor JR; Lawrence AJ
J Pharm Pharmacol; 1990 May; 42(5):358-9. PubMed ID: 1976787
[TBL] [Abstract][Full Text] [Related]
8. Comparison of [Dmt1]DALDA and DAMGO in binding and G protein activation at mu, delta, and kappa opioid receptors.
Zhao GM; Qian X; Schiller PW; Szeto HH
J Pharmacol Exp Ther; 2003 Dec; 307(3):947-54. PubMed ID: 14534366
[TBL] [Abstract][Full Text] [Related]
9. delta-Opioid receptor binding in mouse brain: evidence for heterogeneous binding sites.
Sofuoglu M; Portoghese PS; Takemori AE
Eur J Pharmacol; 1992 Jun; 216(2):273-7. PubMed ID: 1327813
[TBL] [Abstract][Full Text] [Related]
10. Differential binding of opioid peptides and other drugs to two subtypes of opioid delta ncx binding sites in mouse brain: further evidence for delta receptor heterogeneity.
Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
Peptides; 1993; 14(5):893-907. PubMed ID: 8284266
[TBL] [Abstract][Full Text] [Related]
11. Pseudoirreversible binding characteristics of [D-Ala2,Glu4]deltorphin and its Cys4 substituted derivative to delta-opioid receptors.
Wild KD; Horan PJ; Misicka A; Lipkowski A; Haaseth RC; Matsunaga TO; Hruby VJ; Toth G; Borsodi A; Yamamura HI
Eur J Pharmacol; 1993 Jun; 246(1):25-31. PubMed ID: 8394818
[TBL] [Abstract][Full Text] [Related]
12. Interaction of [D-Pen2,D-Pen5]enkephalin and [D-Ala2,Glu4]deltorphin with delta-opioid receptor subtypes in vivo.
Vanderah T; Takemori AE; Sultana M; Portoghese PS; Mosberg HI; Hruby VJ; Haaseth RC; Matsunaga TO; Porreca F
Eur J Pharmacol; 1994 Feb; 252(2):133-7. PubMed ID: 8157053
[TBL] [Abstract][Full Text] [Related]
13. Identification of a human delta opioid receptor: cloning and expression.
Knapp RJ; Malatynska E; Fang L; Li X; Babin E; Nguyen M; Santoro G; Varga EV; Hruby VJ; Roeske WR
Life Sci; 1994; 54(25):PL463-9. PubMed ID: 8201839
[TBL] [Abstract][Full Text] [Related]
14. Effect of intracerebroventricular beta-funaltrexamine on mu opioid receptors in the rat brain: consideration of binding condition.
Liu-Chen LY; Yang HH; Li S; Adams JU
J Pharmacol Exp Ther; 1995 Jun; 273(3):1047-56. PubMed ID: 7791074
[TBL] [Abstract][Full Text] [Related]
15. Effects of some 7-arylidene and 7-heteroarylidene morphinan-6-ones on the antinociceptive activity of [D-Pen2, D-Pen5]enkephalin and [D-Ala2, Glu4]deltorphin II and on multiple opioid receptors.
Bhargava HN; Zhao GM; Bian JT; Nan Y; Upadhyaya SP; Xu W; Dunn WJ; Bauer L
Peptides; 1997; 18(5):695-701. PubMed ID: 9213363
[TBL] [Abstract][Full Text] [Related]
16. Activity of mu- and delta-opioid agonists in vas deferens from mice deficient in MOR gene.
Maldonado R; Severini C; Matthes HW; Kieffer BL; Melchiorri P; Negri L
Br J Pharmacol; 2001 Apr; 132(7):1485-92. PubMed ID: 11264242
[TBL] [Abstract][Full Text] [Related]
17. Binding of BW 373U86, a non-peptidic delta opioid receptor agonist, is not regulated by guanine nucleotides and sodium.
Wild KD; Fang L; McNutt RW; Chang KJ; Toth G; Borsodi A; Yamamura HI; Porreca F
Eur J Pharmacol; 1993 Aug; 246(3):289-92. PubMed ID: 8223952
[TBL] [Abstract][Full Text] [Related]
18. Interaction of opioid peptides and other drugs with multiple delta ncx binding sites in rat brain: further evidence for heterogeneity.
Xu H; Partilla JS; de Costa BR; Rice KC; Rothman RB
Peptides; 1992; 13(6):1207-13. PubMed ID: 1337380
[TBL] [Abstract][Full Text] [Related]
19. Interaction between the mu-agonist dermorphin and the delta-agonist [D-Ala2, Glu4]deltorphin in supraspinal antinociception and delta-opioid receptor binding.
Negri L; Improta G; Lattanzi R; Potenza RL; Luchetti F; Melchiorri P
Br J Pharmacol; 1995 Dec; 116(7):2931-8. PubMed ID: 8680727
[TBL] [Abstract][Full Text] [Related]
20. Effects of NMDA receptor antagonists on delta1- and delta2-opioid receptor agonists-induced changes in the mouse brain [3H]DPDPE binding.
Cao YJ; Bian JT; Bhargava HN
Eur J Pharmacol; 1997 Sep; 335(2-3):161-6. PubMed ID: 9369369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
